Compositions for targeted delivery of siRNA

Details for Australian Patent Application No. 2011219941 (hide)

Owner Arrowhead Research Corporation

Inventors Hadwiger, Philipp; Hoffmann, Torsten; Kitas, Eric A.; Lewis, David L.; Mohr, Peter; Rozema, David B.; Thuer, Wilma; Valis, Linda Christine; Wakefield, Darren H.

Agent Pizzeys

Pub. Number AU-A-2011219941

PCT Pub. Number WO2011/104169

Priority 61/307,490 24.02.10 US

Filing date 18 February 2011

Wipo publication date 1 September 2011

International Classifications

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 - Double-stranded nucleic acids or oligonucleotides

A61K 47/18 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/87 Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/104169 Priority application(s): WO2011/104169

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011219954-Encoder and encoding method providing incremental redundancy

2011219933-Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field